JBC: Paving the way for disease-resistant rice
Researchers have uncovered an unusual protein activity in rice that might give plants an edge in the evolutionary arms race against rice blast disease, a major threat to rice production.
Magnaporthe oryzae, the fungus that leads to the disease, creates lesions on rice plants that reduce the yield and quality of grain, causing a loss of up to a third of the annual global rice harvest.

A sustainable approach to ward off the fungus has not yet been developed. Cost and environmental concerns limit the use of toxic fungicides. And a phenomenon called linkage drag, where undesirable genes are transferred along with desired ones, makes it difficult to breed varieties with improved disease resistance that still produce grain at a desired rate.
Gene-editing technologies that precisely insert genes in rice plants eventually could overcome linkage drag, but first, genes that boost rice immunity need to be identified or engineered.
at the John Innes Centre and a team of researchers in Japan and the U.K. in the Journal of Biological Chemistry that a particular rice immune receptor — from a class of receptors that typically recognize single pathogenic proteins — triggers immune reactions in response to two fungal proteins. The genes encoding this receptor could become a template for engineered receptors that detect multiple fungal proteins and thereby improve disease resistance.
Rice blast fungus deploys proteins known as effectors inside rice cells. In response, rice plants have evolved genes that encode nucleotide-binding leucine-rich repeat proteins, or NLRs, which are intracellular immune receptors that bait specific fungal effectors. After an NLR receptor’s specific fungal effector binds to the bait, signaling pathways are initiated that cause cell death.
The cells “die in a very localized area so the rest of the plant is able to survive,” Banfield said. “It’s almost like sacrificing your finger to save the rest of your body.”
After learning that the fungal effectors AVR-Pia and AVR-Pik have similar structures, the researchers sought to find out whether any rice NLRs known to bind to one of these effectors might also bind to the other, Banfield said.
The team introduced different combinations of rice NLRs and fungal effectors into tobacco (a model for studying plant immunity) and also used rice plants to show if any unusual pairs could elicit immune responses. An AVR-Pik-binding rice NLR called Pikp triggered cell death in response to AVR-Pik as expected, but the experiments showed that plants expressing this NLR also partially reacted to AVR-Pia.
Looking at the unexpected pairing using X-ray crystallography, the authors saw that the rice NLR possessed two separate docking sites for AVR-Pia and AVR-Pik.
Pikp causes meager immune reactions after binding AVR-Pia; however, the receptor’s DNA could be modified to improve its affinity for mismatched effectors, Banfield said. “If we can find a way to harness that capability, we could produce a super NLR that’s able to bind multiple pathogen effectors.”
As an ultimate endgame, gene-editing technologies could be used to insert enhanced versions of NLRs — such as Pikp — into plants, Banfield said, which could tip the scale in favor of healthy rice crops.
Enjoy reading 91影库Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from 91影库Today
Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

Defeating deletions and duplications
Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader鈥揥illi syndrome.

Using 'nature鈥檚 mistakes' as a window into Lafora disease
After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer鈥檚 code through functional connections
A machine learning鈥揹erived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.

Gaze into the proteomics crystal ball
The 15th International Symposium on Proteomics in the Life Sciences symposium will be held August 17鈥21 in Cambridge, Massachusetts.